| Efficacy and safety of cholesterol-lowering treatment. | |
| | |
MedLine Citation:
|
PMID: 16473115 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Malcolm Law; Nicholas J Wald |
Related Documents
:
|
19573945 - Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or withou... 8291675 - Determination of cholesterol and cholesterol ester with novel enzyme microsensors. 7918615 - Increased cholesterol esterase level by cholesterol loading of rat pancreatoma cells. 12217665 - Reduced frequency of high cholesterol levels among patients with intracerebral haemorrh... 11210045 - Deep-stacked broiler litter as a protein supplement for dairy replacement heifers. 16162705 - Treatment of cachexia with ghrelin in patients with copd. |
Publication Detail:
|
Type: Comment; Letter |
Journal Detail:
|
Title: Lancet Volume: 367 ISSN: 1474-547X ISO Abbreviation: Lancet Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-02-13 Completed Date: 2006-02-23 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 2985213R Medline TA: Lancet Country: England |
Other Details:
|
Languages: eng Pagination: 469-70; author reply 470-1 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cholesterol, LDL
/
blood Coronary Disease / prevention & control Dose-Response Relationship, Drug Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects, therapeutic use* Hypercholesterolemia / drug therapy* Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| Comments/Corrections | |
Comment On:
|
Lancet. 2005 Oct 8;366(9493):1267-78
[PMID:
16214597
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Back pain emergencies.
Next Document: Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct hum...